Showing results (1-10 of 607) with videos related to

Sort By:
Pageof 61
British Journal of Cancer|July 20, 2001
Genetic heterogeneity and clonal evolution in neuroblastomaJ Mora, N K Cheung, W L Gerald
The Oncologist|June 26, 2001
Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experienceJ Mora, W L Gerald, J Qin, et al.
Medical and Pediatric Oncology|December 7, 2000
Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterationsJ Mora, M Akram, N K Cheung, et al.
The Journal of Molecular Diagnostics : JMD|March 29, 2001
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1pJ Mora, N K Cheung, B H Kushner, et al.
Cancer Research|September 18, 2001
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cellJ Mora, N K Cheung, G Juan, et al.
Cancer|February 17, 2001
Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional diseaseJ Mora, N K Cheung, L Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastomaJ Mora, N K Cheung, L Chen, et al.
Medical and Pediatric Oncology|July 24, 2001
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastomaK Kramer, W L Gerald, B H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastomaK Kramer, W L Gerald, B H Kushner, et al.
Medical and Pediatric Oncology|February 9, 1999
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosisP Cole, M Ladanyi, W L Gerald, et al.
Pageof 61